Topotecan, Ara-C, Cisplatin and Prednisolone (Toposhap) for Patients with Refractory and Relapsing Lymphomas: Results of a Phase II Trial

Publisher： Karger

E-ISSN： 1421-9662|116|4|275-278

ISSN： 0001-5792

Source： Acta Haematologica, Vol.116, Iss.4, 2006-11, pp. : 275-278

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Topotecan, Ara-C, Cisplatin and Prednisolone (TOPOSHAP) for Patients with Refractory and Relapsing Lymphomas: Results of a Phase I Trial

By  

Acta Haematologica, Vol. 112, Iss. 3, 2004-09 ,pp. : 121-125

Karger

Access to resources Recommend Favorite

Is Cisplatin Required for the Treatment of Non-Small-Cell Lung Cancer? Experience and Preliminary Results of a Phase I/II Trial with Topotecan and Vinorelbine

By  

Oncology, Vol. 61, Iss. 1, 2001-09 ,pp. : 35-41

Karger

Access to resources Recommend Favorite

A Phase I Clinical Trial of Topotecan Given Every 2 Weeks in Patients with Refractory Solid Tumors

By  

Oncology, Vol. 61, Iss. 4, 2001-11 ,pp. : 265-270

Karger

Access to resources Recommend Favorite

Lenalidomide, bendamustine and prednisolone exhibits a favourable safety and efficacy profile in relapsed or refractory multiple myeloma: final results of a phase 1 clinical trial OSHO – #077

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 162, Iss. 2, 2013-07 ,pp. : 202-209

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Efficacy of Mitoxantrone and Ara-C with or without Etoposide Salvage Chemotherapy in Adult Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia: Retrospective Multicenter Study of the Korean Adult ALL Working Party

By  

Acta Haematologica, Vol. 133, Iss. 1, 2014-08 ,pp. : 91-97

Karger

Access to resources Recommend Favorite